Pyridinyl derivatives comprising a cyanoguanidine or squaric acid moiety
EP2453883A1
Method for predicting the utility of administering nicotinic acid or a precursor or prodrug thereof to reduce the severity of side-effects of cancer treatment with nicotinamide phosphoribosyltransferase inhibitors
CA2764694A1
Pyridinyl derivatives asinhibitors of enzyme nicotinamide phosphoribosyltransferase
WO2010109008A1
Prodrugs of substituted 3-(4-hydroxyphenyl)-indolin-2-ones
WO2010066709A1
Novel pyridinyl acrylamide derivatives
EP2342181A1
Novel urea and thiourea derivatives
MX2010014310A
Squaric acid derivatives as inhibitors of the nicotinamide.
CN102083428A
Methods of treatment employing prolonged continuous infusion of Belinostat
